Ciphergen Shares Slide 11 Percent After It Exchanged Debt, Cash | GenomeWeb
NEW YORK (GenomeWeb News) — Shares in Ciphergen were down 10.91 percent, or $.12, at $.98 in mid-afternoon trading today after the company said it finished exchanging $27.5 million worth of outstanding debt for a new series of notes worth $16.5 million, plus cash.

Ciphergen said it finished the exchange of 4.5-percent senior notes due 2008 for a new series of 7-percent convertible senior notes due 2011, together with $11 million in cash.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Harold Varmus, a former NIH director, says that proposed reductions to the agency's budget are worrisome.

The Genome 10K project is to sequence about 10,000 vertebrate genomes, including ones of endangered species, Digital Trends reports.

The new Coalition to Save NIH Funding aims to educate lawmakers and the public on the significance of biomedical research.

In PLOS this week: analysis of viral sequences from human blood samples, gut microbiomes of heart failure patients, and more.